417 related articles for article (PubMed ID: 25542050)
21. A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Teethaisong Y; Hobbs G; Nakouti I; Evans K; Eumkeb G
Diagn Microbiol Infect Dis; 2018 May; 91(1):85-88. PubMed ID: 29422274
[TBL] [Abstract][Full Text] [Related]
22. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Bou G; Vila J; Seral C; Castillo FJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
[TBL] [Abstract][Full Text] [Related]
23. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
Vlek AL; Frentz D; Haenen A; Bootsma HJ; Notermans DW; Frakking FN; de Greeff SC; Leenstra T;
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
[TBL] [Abstract][Full Text] [Related]
24. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
25. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
[TBL] [Abstract][Full Text] [Related]
26. Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae.
Tamma PD; Huang Y; Opene BN; Simner PJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):6425-9. PubMed ID: 27503655
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Moczygemba LR; Frei CR; Burgess DS
Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
[TBL] [Abstract][Full Text] [Related]
28. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
[TBL] [Abstract][Full Text] [Related]
29. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
[TBL] [Abstract][Full Text] [Related]
30. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
31. Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases.
Isla A; Canut A; Arribas J; Asín-Prieto E; Rodríguez-Gascón A
Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):511-9. PubMed ID: 26782093
[TBL] [Abstract][Full Text] [Related]
32. Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
Caméléna F; Cointe A; Mathy V; Hobson C; Doit C; Bercot B; Decré D; Podglajen I; Dortet L; Monjault A; Bidet P; Bonacorsi S; Birgy A
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950336
[TBL] [Abstract][Full Text] [Related]
33. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Asensio Á; Cantero M; Shaw E; Vergara-López S
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
[TBL] [Abstract][Full Text] [Related]
34. Rapid detection of resistance to carbapenems and cephalosporins in Enterobacteriaceae using liquid chromatography tandem mass spectrometry.
Tadros M; Goneau L; Romaschin A; Jarvis M; Matukas L
PLoS One; 2018; 13(11):e0206842. PubMed ID: 30412608
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
[TBL] [Abstract][Full Text] [Related]
36. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
Hartl R; Widhalm S; Kerschner H; Apfalter P
Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
Liu PY; Shi ZY; Tung KC; Shyu CL; Chan KW; Liu JW; Wu ZY; Kao CC; Huang YC; Lin CF
J Infect Dev Ctries; 2014 Mar; 8(3):289-96. PubMed ID: 24619258
[TBL] [Abstract][Full Text] [Related]
38. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
Bradford PA; Kazmierczak KM; Biedenbach DJ; Wise MG; Hackel M; Sahm DF
Antimicrob Agents Chemother; 2015 Dec; 60(3):1385-92. PubMed ID: 26666920
[TBL] [Abstract][Full Text] [Related]
39. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
40. Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.
Saw HT; Webber MA; Mushtaq S; Woodford N; Piddock LJ
J Antimicrob Chemother; 2016 Jun; 71(6):1510-9. PubMed ID: 26945714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
